Hjem › Kimcelle- og embryonalt cancer › Texas
Kimcelle- og embryonalt cancer kliniske forsøg i Texas
7 studier for Kimcelle- og embryonalt cancer søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
RekruttererFase 1
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Driscoll Children's Hospital, Corpus Christi
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- University of Texas Health Science Center at San Antonio, San Antonio
RekruttererFase 3
Alder 11 til 50 · Alle køn · Opdateret 1. sep. 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- og 12 flere
RekruttererFase 3
Alle aldre · Alle køn · Opdateret 25. aug. 2026 · NCT03067181Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- M D Anderson Cancer Center, Houston
RekruttererFase 1/2
Alder 12 til 80 · Alle køn · Opdateret 7. aug. 2026 · NCT05092451C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- Texas Children's Hospital, Houston
RekruttererFase 1
12 Months – 25 Years · Alle køn · Opdateret 3. aug. 2026 · NCT04099797A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116A Study of ZW251 in Participants With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT07164313Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.